Edesa Biotech, Inc.EDSANASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank80
3Y CAGR+2.6%
5Y CAGR-4.4%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+2.6%/yr
vs +20.0%/yr prior
5Y CAGR
-4.4%/yr
Recent acceleration
Acceleration
-17.5pp
Decelerating
Percentile
P80
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$4.58M+8.0%
2025$4.24M+2.7%
2024$4.13M-2.6%
2023$4.24M-15.7%
2022$5.04M-12.2%
2021$5.73M+69.5%
2020$3.38M+65.4%
2019$2.05M-25.8%
2018$2.76M-6.4%
2017$2.94M-